Evidence map›Paper›PMID 42297957›Full record

ArticleEMBO reports2026

The E3 ligase MKRN2 prevents DRiP accumulation in stress granules and maintains granulostasis.

Emmanuel Amzallag, Yehuda M Danino, Valentina Secco, Serena Carra, Eran Hornstein

Abstract read
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emmanuel AmzallagDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.ORCID 0009-0008-9423-7776
Yehuda M DaninoDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0001-5295-0487
Valentina SeccoDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.ORCID 0009-0000-7523-7094
Serena CarraDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.ORCID 0000-0003-0939-0140
Eran HornsteinDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. Eran.Hornstein@weizmann.ac.il.ORCID 0000-0002-5534-1924

Funding

Association Française Contre les Myopathie (AFM) 24882,28680Israel Science Foundation (ISF) 3497/21,424/22Muscular Dystrophy Association (MDA) 1280000
6 · The paper itself

Abstract

Stress granules (SGs) are transient cytoplasmic biomolecular condensates that play a role in the cellular response to proteotoxic stress. It has been previously shown that ubiquitination regulates SG dynamics; however, the specific mechanisms by which ubiquitin affects SGs are not fully understood. Here, using proximity proteomics, we discover that the recruitment of several E3 ubiquitin ligases, VCP cofactors and HSP70 to SGs is dependent on the activity of the E1 ubiquitin ligase UBA1. The RNA-binding E3 ubiquitin-protein ligase Makorin 2 (MKRN2) is strongly depleted from SGs in the absence of UBA1 function. MKRN2 promotes both the proper formation of SGs and their disassembly following stress recovery, by preventing the accumulation of misfolding-prone defective ribosomal products (DRiPs) within SGs. Therefore, MKRN2 is a novel regulator of SGs that mediates the maintenance of granulostasis.

Indexed as

RibonucleoproteinsRibosomal ProteinsStress GranulesUbiquitin-Protein LigasesHSP70 Heat-Shock ProteinsHumansNerve Tissue ProteinsProtein BindingStress, PhysiologicalHSP70 Heat-Shock ProteinsMakorin ring finger protein 1Nerve Tissue ProteinsRibonucleoproteinsRibosomal ProteinsUbiquitin-Protein Ligases

Identifiers

PMID42297957
PMCPMC13458048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.